Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Green

Showing results (911-920 of 964) with videos related to

Pageof 97
Sort By:
Schizophrenia Research|October 13, 2014
The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2Bruce I Turetsky, Erich M Dress, David L Braff, et al.
Journal of Clinical Microbiology|November 6, 2024
Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 <i>plus</i> test on nasal and nasopharyngeal swabsAlexander L Greninger, Allan Larcena, Amrish Patel, et al.
JAMA Psychiatry|October 10, 2019
Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) StudyTiffany A Greenwood, Laura C Lazzeroni, Adam X Maihofer, et al.
Schizophrenia Research|May 28, 2017
Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extensionNeal R Swerdlow, Gregory A Light, Michael L Thomas, et al.
Biological Psychiatry|December 15, 2010
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophreniaRobert W Buchanan, Richard S E Keefe, Jeffrey A Lieberman, et al.
Schizophrenia Bulletin|June 7, 2014
Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family studyGregory Light, Tiffany A Greenwood, Neal R Swerdlow, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 16, 2025
Evaluation of Cepheid Xpert Xpress CoV-2/Flu/RSV plus for nasal and nasopharyngeal specimens tested in CLIA-accredited and CLIA-waived settingsErin McElvania, Deepa Rao, Alexander L Greninger, et al.
Cell Metabolism|April 6, 2017
SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin SecretionKristin A Anderson, Frank K Huynh, Kelsey Fisher-Wellman, et al.
Frontiers in Physiology|April 19, 2021
Study Protocol: The Heart and Brain StudySana Suri, Daniel Bulte, Scott T Chiesa, et al.
Schizophrenia Research|March 3, 2015
A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapyL Fredrik Jarskog, Martin T Lowy, Richard A Grove, et al.
Pageof 97

Showing results (911-920 of 964) with videos related to

Sort By:
Pageof 97
Schizophrenia Research|October 13, 2014
The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2Bruce I Turetsky, Erich M Dress, David L Braff, et al.
Journal of Clinical Microbiology|November 6, 2024
Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 <i>plus</i> test on nasal and nasopharyngeal swabsAlexander L Greninger, Allan Larcena, Amrish Patel, et al.
JAMA Psychiatry|October 10, 2019
Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) StudyTiffany A Greenwood, Laura C Lazzeroni, Adam X Maihofer, et al.
Schizophrenia Research|May 28, 2017
Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extensionNeal R Swerdlow, Gregory A Light, Michael L Thomas, et al.
Biological Psychiatry|December 15, 2010
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophreniaRobert W Buchanan, Richard S E Keefe, Jeffrey A Lieberman, et al.
Schizophrenia Bulletin|June 7, 2014
Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family studyGregory Light, Tiffany A Greenwood, Neal R Swerdlow, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 16, 2025
Evaluation of Cepheid Xpert Xpress CoV-2/Flu/RSV plus for nasal and nasopharyngeal specimens tested in CLIA-accredited and CLIA-waived settingsErin McElvania, Deepa Rao, Alexander L Greninger, et al.
Cell Metabolism|April 6, 2017
SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin SecretionKristin A Anderson, Frank K Huynh, Kelsey Fisher-Wellman, et al.
Frontiers in Physiology|April 19, 2021
Study Protocol: The Heart and Brain StudySana Suri, Daniel Bulte, Scott T Chiesa, et al.
Schizophrenia Research|March 3, 2015
A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapyL Fredrik Jarskog, Martin T Lowy, Richard A Grove, et al.
Pageof 97